22Q11 Deletion Syndrome
7 clinical trials · Condition
◉ Watch 22Q11 Deletion Syndrome
| Record | Firm | Date |
|---|---|---|
| NB-001 in Children and Adolescents With 22q11 Deletion Syndrome (NCT05290493) | Nobias Therapeutics, Inc. | 2022-02-10 |
| GROWing Up With Rare GENEtic Syndromes (NCT04463316) | dr. Laura C. G. de Graaff-Herder | 2018-10-01 |
| SNP-based Microdeletion and Aneuploidy RegisTry (SMART) (NCT02381457) | Natera, Inc. | 2015-04-01 |
| Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome. (NCT02070211) | Bambino Gesù Hospital and Research Institute | 2014-06-01 |
Track 22Q11 Deletion Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.